Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Miromatrix Medical Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 28 | 31 | +3 |
| Shares | 3.75M | 6.64M | +2.89M (+77.1%) |
| Value | $11.2M | $11.1M | −$58.8K (−0.5%) |
New holders (6)
Institutions that held Miromatrix Medical Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perkins Capital Management Inc | 151,320 | $254.0K | 0.24% |
| Raymond James & Associates | 64,300 | $108.0K | 0.00% |
| HighMark Wealth Management LLC | 41,972 | $70.5K | 0.05% |
| Worth Venture Partners, LLC | 21,800 | $36.6K | 0.02% |
| Tradition Wealth Management, LLC | 21,275 | $36.0K | 0.00% |
| UBS Group AG | 6,980 | $11.7K | 0.00% |
Sold out (3)
Institutions that held Miromatrix Medical Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 19,739 | $59.0K |
| JPMorgan Chase & Co | 1,645 | $5.00K |
| Bank of America Corp | 32 | $96 |